Tab. V.

Current US Food and Drug Administration (FDA) approved medications for overactive bladder treatment [82]

Medication	FDA approval
Oxybutynin ER	June 1999
Tolterodine tartrate ER	December 2000
Transdermal oxybutynin	March 2004
Trospium chloride IR	May 2004
Solifenacin	November 2004
Darifenacin	December 2004
Trospium chloride ER	August 2007
Fesoterodine	October 2008
Oxybutynin chloride gel 10%	January 2009
Oxybutynin chloride gel 3%	July 2011
Mirabegron	June 2012
Onabotulinum toxin A	January 2013

ER – extended release, IM – immediate release